Adam Berger

TitleAssoc Prof CHP
InstitutionThomas Jefferson University
DepartmentNursing - Undergraduate
Address1025 Walnut St.
Philadelphia PA 19107
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    F31NS044743     (BERGER, ADAM C)Aug 1, 2002
    NIH
    Analysis of Niemann-Pick C Protein (NPCI) Function
    Role: Principal Investigator

    R13FD005355     (BEACHY, SARAH H)Jun 5, 2015 - May 31, 2018
    NIH
    Forum on Regenerative Medicine
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gandarillas S, Berger A, Stephenson R, Mehregan D, Dasgeb B. Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoid. Int J Dermatol. 2024 Nov 26. PMID: 39592443.
      Citations:    
    2. Van Decar SG, Carpenter EL, Adams AM, Chick RC, Clifton GT, Stojadinovic A, Vreeland TJ, Valdera FA, Tiwari A, O'Shea AE, McCarthy PM, Hale DF, Bohan PMK, Hickerson AT, Cindass JL, Hyngstrom J, Berger AC, Jakub JW, Sussman JJ, Shaheen M, Yu X, Wagner T, Faries MB, Peoples GE. Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial. Cancer Treat Res Commun. 2024 Sep 11; 41:100843. PMID: 39305541.
      Citations:    
    3. Ragsdale M, Dow B, Fernandes D, Han Y, Parikh A, Boyapati K, Landry CS, Kimbrough CW, Koshenkov VP, Preskitt JT, Berger AC, Davis CH. Sentinel lymph node positivity in melanoma: Which risk prediction tool is most accurate? Surgery. 2024 Jul 11. PMID: 38997863.
      Citations:    
    4. Machado P, Tahmasebi A, Fallon S, Liu JB, Dogan BE, Needleman L, Lazar M, Willis AI, Brill K, Nazarian S, Berger A, Forsberg F. Characterizing Sentinel Lymph Node Status in Breast Cancer Patients Using a Deep-Learning Model Compared With Radiologists' Analysis of Grayscale Ultrasound and Lymphosonography. Ultrasound Q. 2024 Sep 01; 40(3). PMID: 38958999.
      Citations:    
    5. Uijterwijk BA, Lemmers DH, Ghidini M, Wilmink H, Zaniboni A, Salvia R, Kito Fusai G, Groot Koerkamp B, Koek S, Ghorbani P, Zerbi A, Nappo G, Luyer M, Goh BKP, Roberts KJ, Boggi U, Mavroeidis VK, White S, Kazemier G, Bj?rnsson B, Serradilla-Mart?n M, House MG, Alseidi A, Ielpo B, Mazzola M, Jamieson N, Wellner U, Soonawalla Z, Cab?s SS, Dalla Valle R, Pessaux P, Vladimirov M, Kent TS, Tang CN, Fisher WE, Kleeff J, Mazzotta A, Suarez Mu?oz MA, Berger AC, Ball CG, Korkolis D, Bannone E, Ferarri C, Besselink MG, Abu Hilal M. The Five Periampullary Cancers, not Just Different Siblings but Different Families: An International Multicenter Cohort Study. Ann Surg Oncol. 2024 Jun 18. PMID: 38888860.
      Citations:    
    6. Harris L, Shankar LK, Hildebrandt C, Rubinstein WS, Langlais K, Rodriguez H, Berger A, Freymann J, Huang EP, Williams PM, Claude Zenklusen J, Ochs R, Tezak Z, Sahiner B. Resource requirements to accelerate clinical applications of next generation sequencing and radiomics: Workshop commentary and review. J Natl Cancer Inst. 2024 Jun 12. PMID: 38867688.
      Citations:    
    7. Uijterwijk BA, Lemmers DH, Ghidini M, Wilmink JW, Zaniboni A, Fusai GK, Zerbi A, Koerkamp BG, Luyer M, Ghorbani P, Salvia R, White S, Ielpo B, Goh BKP, Boggi U, Kazemier G, House MG, Mavroeidis VK, Bj?rnsson B, Mazzola M, Serradilla M, Korkolis D, Alseidi A, Roberts KJ, Soonawalla Z, Pessaux P, Fisher WE, Koek S, Kent TS, Vladimirov M, Bolm L, Jamieson N, Dalla Valle R, Kleeff J, Mazzotta A, Suarez Mu?oz MA, Cab?s SS, Ball CG, Berger AC, Ferarri C, Besselink MG, Hilal MA. The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study. Br J Cancer. 2024 May 28. PMID: 38806725.
      Citations:    
    8. Manne S, Heckman CJ, Frederick S, Schaefer AA, Studts CR, Khavjou O, Honeycutt A, Berger A, Liu H. A Digital Intervention to Improve Skin Self-Examination Among Survivors of Melanoma: Protocol for a Type-1 Hybrid Effectiveness-Implementation Randomized Trial. JMIR Res Protoc. 2024 Feb 12; 13:e52689. PMID: 38345836.
      Citations:    
    9. Turkheimer LM, Petroni GR, Berger AC, Schroen AT, Brenin DR, Lazar M, Libby B, Janowski EM, Showalter TN, Showalter SL. Novel Form of Breast Intraoperative Radiation Therapy with CT-Guided High-Dose-Rate Brachytherapy: Interim Results of a Prospective Phase II Clinical Trial. J Am Coll Surg. 2023 Oct 23. PMID: 37870228.
      Citations:    
    10. Carpenter EL, Van Decar S, Adams AM, O'Shea AE, McCarthy P, Chick RC, Clifton GT, Vreeland T, Valdera FA, Tiwari A, Hale D, Kemp Bohan P, Hickerson A, Smolinsky T, Thomas K, Cindass J, Hyngstrom J, Berger AC, Jakub J, Sussman JJ, Shaheen MF, Yu X, Wagner TE, Faries M, Peoples GE. Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis. J Immunother Cancer. 2023 08; 11(8). PMID: 37536936.
      Citations:    
    11. Gazivoda VP, Koshenkov VP, Kangas-Dick AW, Greenbaum A, Davis C, Smith FO, Hilden PD, Berger AC. Factors Associated With Upstaging of Melanoma Thickness on Final Excision. J Surg Res. 2023 May 05; 289:253-260. PMID: 37150080.
      Citations:    
    12. Manne S, Pagoto S, Peterson S, Heckman C, Kashy D, Berger A, Studts C, Negr?n R, Buller D, Paddock L, Gallo J, Kulik A, Frederick S, Pesanelli M, Domider M, Grosso M. Facebook Intervention for Young-Onset Melanoma Survivors and Families: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023 Jan 24; 12:e39640. PMID: 36692933.
      Citations:    
    13. Machado P, Liu JB, Needleman L, Lazar M, Willis AI, Brill K, Nazarian S, Berger A, Forsberg F. Sentinel Lymph Node Identification in Post Neoadjuvant Chemotherapy Breast Cancer Patients Undergoing Surgical Excision Using Lymphosonography. J Ultrasound Med. 2023 Jan 02. PMID: 36591785.
      Citations:    
    14. Machado P, Liu JB, Needleman L, Lazar M, Willis AI, Brill K, Nazarian S, Berger A, Forsberg F. Sentinel Lymph Node Identification in Patients With Breast Cancer Using Lymphosonography. Ultrasound Med Biol. 2023 Feb; 49(2):616-625. PMID: 36446688.
      Citations:    
    15. Lehner MH, Walker J, Temcinaite K, Herlihy A, Taschner M, Berger AC, Corbett AH, Dirac Svejstrup AB, Svejstrup JQ. Yeast Smy2 and its human homologs GIGYF1 and -2 regulate Cdc48/VCP function during transcription stress. Cell Rep. 2022 10 25; 41(4):111536. PMID: 36288698.
      Citations:    
    16. Adams AM, Carpenter EL, Clifton GT, Vreeland TJ, Chick RC, O'Shea AE, McCarthy PM, Kemp Bohan PM, Hickerson AT, Valdera FA, Tiwari A, Hale DF, Hyngstrom JR, Berger AC, Jakub JW, Sussman JJ, Shaheen MF, Yu X, Wagner TE, Faries MB, Peoples GE. Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial. Cancer Immunol Immunother. 2022 Sep 01. PMID: 36045304.
      Citations:    
    17. Davis CH, Ho J, Stephenson R, August DA, Gee H, Weiner J, Alexander HR, Pitt HA, Berger AC. Virtual Tumor Board Increases Provider Attendance and Case Presentations. JCO Oncol Pract. 2022 10; 18(10):e1603-e1610. PMID: 35939774.
      Citations:    
    18. Lamm R, Hewitt DB, Li M, Powell AC, Berger AC. Socioeconomic Status and Gastric Cancer Surgical Outcomes: A National Cancer Database Study. J Surg Res. 2022 07; 275:318-326. PMID: 35320743.
      Citations:    
    19. Gribkova Y, Davis CH, Greenbaum AA, Lu SE, Berger AC. Effect of the COVID-19 pandemic on surgical oncology practice-Results of an SSO survey. J Surg Oncol. 2022 Mar 06. PMID: 35249232.
      Citations:    
    20. Dasgeb B, Pajouhanfar S, Jazayeri A, Schoenberg E, Kumar G, Fortina P, Berger AC, Uitto J. Novel PTCH1 and concurrent TP53 mutations in four patients with numerous non-syndromic basal cell carcinomas: The paradigm of oncogenic synergy. Exp Dermatol. 2021 Dec 04. PMID: 34862824.
      Citations:    
    21. Berger AC, Koshenkov V. Post-Publication Discussion: In Reply. Ann Surg Oncol. 2022 02; 29(2):818-819. PMID: 34853939.
      Citations:    
    22. Davis CH, Ho J, Greco SH, Koshenkov VP, Vidri RJ, Farma JM, Berger AC. COVID-19 is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States. Ann Surg Oncol. 2022 Mar; 29(3):1629-1635. PMID: 34797482.
      Citations:    
    23. Eckhoff A, Farrow NE, Silvestri C, Stroobant E, Intenzo C, Leddy M, Tyler DS, Berger A, Beasley GM. How much time is enough? Sentinel lymph node mapping time depends on the radiotracer agent. J Surg Oncol. 2022 Mar; 125(4):712-718. PMID: 34786720.
      Citations:    
    24. Manne S, Kashy DA, Pagoto S, Peterson SK, Heckman CJ, Gallo J, Berger A, Buller DB, Kulik A, Frederick S, Pesanelli M. Family Attitudes and Communication about Sun Protection and Sun Protection Practices among Young Adult Melanoma Survivors and Their Family Members. J Health Commun. 2021 11 02; 26(11):781-791. PMID: 34844521.
      Citations:    
    25. VanderWalde N, Moughan J, Lichtman SM, Jagsi R, Ballo M, VanderWalde A, Mohiuddin M, Meropol NJ, Kachnic L, Berger A, Ajani J, Anne R, Hopkins JL, Arora A, Meyer J, Ellsworth SG, Lee RJ, Green N, Crane CH. The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials. J Geriatr Oncol. 2021 Oct 27. PMID: 34756496.
      Citations:    
    26. Slingluff CL, Lewis KD, Andtbacka R, Hyngstrom J, Milhem M, Markovic SN, Bowles T, Hamid O, Hernandez-Aya L, Claveau J, Jang S, Philips P, Holtan SG, Shaheen MF, Curti B, Schmidt W, Butler MO, Paramo J, Lutzky J, Padmanabhan A, Thomas S, Milton D, Pecora A, Sato T, Hsueh E, Badarinath S, Keech J, Kalmadi S, Kumar P, Weber R, Levine E, Berger A, Bar A, Beck JT, Travers JB, Mihalcioiu C, Gastman B, Beitsch P, Rapisuwon S, Glaspy J, McCarron EC, Gupta V, Behl D, Blumenstein B, Peterkin JJ. Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence. J Immunother Cancer. 2021 Oct; 9(10). PMID: 34599031.
      Citations:    
    27. Brubaker LS, Casciani F, Fisher WE, Wood AL, Cagigas MN, Trudeau MT, Parikh VJ, Baugh KA, Asbun HJ, Ball CG, Behrman SW, Berger AC, Bloomston MP, Callery MP, Christein JD, Fernandez-Del Castillo C, Dillhoff ME, Dixon E, House MG, Hughes SJ, Kent TS, Kunstman JW, Wolfgang CL, Zureikat AH, Vollmer CM, Van Buren G. A risk-adjusted analysis of drain use in pancreaticoduodenectomy: Some is good, but more may not be better. Surgery. 2021 Aug 22. PMID: 34433515.
      Citations:    
    28. Adams AM, Chick RC, Vreeland TJ, Clifton GT, Hale DF, McCarthy PM, O'Shea AE, Bohan PMK, Hickerson AT, Park H, Sloan AJ, Hyngstrom J, Berger AC, Jakub JW, Sussman JJ, Shaheen M, Wagner T, Faries MB, Peoples GE. Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma. Melanoma Res. 2021 08 01; 31(4):378-388. PMID: 34193804.
      Citations:    
    29. Chick RC, Faries MB, Hale DF, Kemp Bohan PM, Hickerson AT, Vreeland TJ, Myers JW, Cindass JL, Brown TA, Hyngstrom J, Berger AC, Jakub JW, Sussman JJ, Shaheen M, Clifton GT, Park H, Sloan AJ, Wagner T, Peoples GE. Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis. Cancer Med. 2021 07; 10(13):4302-4311. PMID: 33982452.
      Citations:    
    30. Casciani F, Trudeau MT, Asbun HJ, Ball CG, Bassi C, Behrman SW, Berger AC, Bloomston MP, Callery MP, Christein JD, Falconi M, Fernandez-Del Castillo C, Dillhoff ME, Dickson EJ, Dixon E, Fisher WE, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, Partelli S, Wolfgang CL, Zureikat AH, Vollmer CM. The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis. Surgery. 2021 Apr 27. PMID: 33931208.
      Citations:    
    31. Gazivoda V, Greenbaum A, Roshal J, Lee J, Reddy L, Rehman S, Kangas-Dick A, Gregory S, Kowzun M, Stephenson R, Laird A, Alexander HR, Berger AC. Assessing the immediate impact of COVID-19 on surgical oncology practice: Experience from an NCI-designated Comprehensive Cancer Center in the Northeastern United States. J Surg Oncol. 2021 Mar 25. PMID: 33765341.
      Citations:    
    32. Vreeland TJ, Clifton GT, Hale DF, Chick RC, Hickerson AT, Cindass JL, Adams AM, Bohan PMK, Andtbacka RHI, Berger AC, Jakub JW, Sussman JJ, Terando AM, Wagner T, Peoples GE, Faries MB. A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis. Ann Surg Oncol. 2021 Feb 27. PMID: 33641012.
      Citations:    
    33. Kangas-Dick AW, Greenbaum A, Gall V, Groisberg R, Mehnert J, Chen C, Moore DF, Berger AC, Koshenkov V. Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma. Ann Surg Oncol. 2021 Jan 23. PMID: 33486642.
      Citations:    
    34. Kangas-Dick A, Berger AC, Koshenkov V. ASO Author Reflections: Gene Expression Profiling for Melanoma: Is it Ready for Prime Time? Ann Surg Oncol. 2021 Jan 21. PMID: 33479864.
      Citations:    
    35. Casciani F, Trudeau MT, Asbun HJ, Ball CG, Bassi C, Behrman SW, Berger AC, Bloomston MP, Callery MP, Christein JD, Falconi M, Fernandez-Del Castillo C, Dillhoff ME, Dickson EJ, Dixon E, Fisher WE, House MG, Hughes SJ, Kent TS, Malleo G, Partelli S, Salem RR, Stauffer JA, Wolfgang CL, Zureikat AH, Vollmer CM. Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development. Surgery. 2020 Dec 29. PMID: 33386129.
      Citations:    
    36. Howard-McNatt M, Dupont E, Tsangaris T, Garcia-Cantu C, Chiba A, Berger AC, Levine EA, Gass JS, Ollila DW, Chagpar AB. Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma in Situ. J Am Coll Surg. 2020 Dec 18. PMID: 33346081.
      Citations:    
    37. Trudeau MT, Casciani F, Maggino L, Seykora TF, Asbun HJ, Ball CG, Bassi C, Behrman SW, Berger AC, Bloomston MP, Callery MP, Castillo CF, Christein JD, Dillhoff ME, Dickson EJ, Dixon E, Fisher WE, House MG, Hughes SJ, Kent TS, Malleo G, Salem RR, Wolfgang CL, Zureikat AH, Vollmer CM. The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy. Ann Surg. 2020 Nov 12. PMID: 33201132.
      Citations:    
    38. Woodward S, Willis A, Lazar M, Berger AC, Tsangaris T. Nipple-sparing mastectomy: A review of outcomes at a single institution. Breast J. 2020 Nov; 26(11):2183-2187. PMID: 33137841.
      Citations:    
    39. Gastman B, Agarwal PK, Berger A, Boland G, Broderick S, Butterfield LH, Byrd D, Fecci PE, Ferris RL, Fong Y, Goff SL, Grabowski MM, Ito F, Lim M, Lotze MT, Mahdi H, Malafa M, Morris CD, Murthy P, Neves RI, Odunsi A, Pai SI, Prabhakaran S, Rosenberg SA, Saoud R, Sethuraman J, Skitzki J, Slingluff CL, Sondak VK, Sunwoo JB, Turcotte S, Yeung CC, Kaufman HL. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. J Immunother Cancer. 2020 Nov; 8(2). PMID: 33199512.
      Citations:    
    40. Zheng R, Nauheim D, Bassig J, Chadwick M, Schultz CW, Krampitz G, Lavu H, Winter JR, Yeo CJ, Berger AC. ASO Author Reflections: Margin-Positive Pancreatic Ductal Adenocarcinoma During Pancreaticoduodenectomy: Additional Resection Does Not Improve Survival. Ann Surg Oncol. 2020 Aug 19. PMID: 32813199.
      Citations:    
    41. Zheng R, Nauheim D, Bassig J, Chadwick M, Schultz CW, Krampitz G, Lavu H, Winter JR, Yeo CJ, Berger AC. Margin-Positive Pancreatic Ductal Adenocarcinoma during Pancreaticoduodenectomy: Additional Resection Does Not Improve Survival. Ann Surg Oncol. 2020 Aug 10. PMID: 32779052.
      Citations:    
    42. Zheng R, Rios-Diaz AJ, Liem S, Devin CL, Evans NR, Rosato EL, Palazzo F, Berger AC. Is the placement of jejunostomy tubes in patients with esophageal cancer undergoing esophagectomy associated with increased inpatient healthcare utilization? An analysis of the National Readmissions Database. Am J Surg. 2020 Jul 25. PMID: 32828519.
      Citations:    
    43. Zheng R, Tham EJH, Rios-Diaz AJ, Grenda TR, Evans NR, Rosato EL, Palazzo F, Berger AC. A 10-year ACS-NSQIP Analysis of Trends in Esophagectomy Practices. J Surg Res. 2020 Jul 16; 256:103-111. PMID: 32683050.
      Citations:    
    44. Woodward SG, Nimtz K, Hookim K, Sevrukov AB, Tsangaris TN, Willis A, Berger AC, Lazar M. Is radial scar on core needle biopsy a risk factor for malignancy? A single-center retrospective review and implications for management. Breast J. 2020 Jul 13. PMID: 32657492.
      Citations:    
    45. Hewitt BB, Bradley E, Berger AC. Margins of Melanoma Excision and Modifications to Standards. Surg Oncol Clin N Am. 2020 Jul; 29(3):339-347. PMID: 32482312.
      Citations:    
    46. Meneveau MO, Petroni GR, Varhegyi NE, Hulse JC, Schroen AT, Brenin DR, Janowski EM, Berger AC, Lazar MA, Simone NL, Showalter TN, Showalter SL. Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT. Brachytherapy. 2020 Jun 19. PMID: 32571746.
      Citations:    
    47. Trudeau MT, Casciani F, Ecker BL, Maggino L, Seykora TF, Puri P, McMillan MT, Miller B, Pratt WB, Asbun HJ, Ball CG, Bassi C, Behrman SW, Berger AC, Bloomston MP, Callery MP, Castillo CF, Christein JD, Dillhoff ME, Dickson EJ, Dixon E, Fisher WE, House MG, Hughes SJ, Kent TS, Malleo G, Salem RR, Wolfgang CL, Zureikat AH, Vollmer CM. The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy. Ann Surg. 2020 Jun 11. PMID: 32541227.
      Citations:    
    48. Moekotte AL, van Roessel S, Malleo G, Rajak R, Ecker BL, Fontana M, Han HS, Rabie M, Roberts KJ, Khalil K, White SA, Robinson S, Halimi A, Zarantonello L, Fusai GK, Gradinariu G, Alseidi A, Bonds M, Dreyer S, Jamieson NB, Mowbray N, Al-Sarireh B, Mavroeidis VK, Soonawalla Z, Napoli N, Boggi U, Kent TS, Fisher WE, Tang CN, Bolm L, House MG, Dillhoff ME, Behrman SW, Nakamura M, Ball CG, Berger AC, Christein JD, Zureikat AH, Salem RR, Vollmer CM, Salvia R, Besselink MG, Abu Hilal M, Aljarrah R, Barrows C, Cagigas MN, Lai ECH, Wellner U, Aversa J, Dickson PV, Ohtsuka T, Dixon E, Zheng R, Kowalski S, Freedman-Weiss M. Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma. Eur J Surg Oncol. 2020 Sep; 46(9):1717-1726. PMID: 32624291.
      Citations:    
    49. Zheng R, Wang O, Bradley E, Lavu H, Winter JR, Rosato EL, Palazzo F, Yeo CJ, Berger AC. Minimally Invasive Distal Pancreatectomy Is Associated with Decreased Postoperative Neutrophil to Lymphocyte Ratio. J Pancreat Cancer. 2020; 6(1):32-39. PMID: 32462109.
      Citations:    
    50. Wang C, Mu Z, Ye Z, Zhang Z, Abu-Khalaf MM, Silver DP, Palazzo JP, Jagannathan G, Fellin FM, Bhattacharya S, Jaslow RJ, Tsangaris TN, Berger A, Neupane M, Cescon TP, Lopez A, Yao K, Chong W, Lu B, Myers RE, Hou L, Wei Q, Li B, Cristofanilli M, Yang H. Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors. Breast Cancer Res Treat. 2020 May 04. PMID: 32367460.
      Citations:    
    51. Abrams RA, Winter KA, Safran H, Goodman KA, Regine WF, Berger AC, Gillin MT, Philip PA, Lowy AM, Wu A, DiPetrillo TA, Corn BW, Seaward SA, Haddock MG, Song S, Jiang Y, Fisher BJ, Katz AW, Mehta S, Willett CG, Crane CH. Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial. Am J Clin Oncol. 2020 Jan 23. PMID: 31985516.
      Citations:    
    52. Tiago M, Capparelli C, Erkes DA, Purwin TJ, Heilman SA, Berger AC, Davies MA, Aplin AE. Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma. Br J Cancer. 2020 Jan 14. PMID: 31932756.
      Citations:    
    53. Rosenbaum SR, Knecht M, Mollaee M, Zhong Z, Erkes DA, McCue PA, Chervoneva I, Berger AC, Lo JA, Fisher DE, Gershenwald JE, Davies MA, Purwin TJ, Aplin AE. FOXD3 Regulates VISTA Expression in Melanoma. Cell Rep. 2020 Jan 14; 30(2):510-524.e6. PMID: 31940493.
      Citations:    
    54. Aderhold K, Wilson M, Berger AC, Levi S, Bennett J. Precision Medicine in the Treatment of Melanoma. Surg Oncol Clin N Am. 2020 Jan; 29(1):1-13. PMID: 31757306.
      Citations:    
    55. Erkes DA, Cai W, Sanchez IM, Purwin TJ, Rogers C, Field CO, Berger AC, Hartsough EJ, Rodeck U, Alnemri ES, Aplin AE. Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via pyroptosis. Cancer Discov. 2019 Dec 03. PMID: 31796433.
      Citations:    
    56. Hassinger TE, Berger AC, Christopher A, Knisely AT, Mehaffey JH, Brenin DR, Schroen AT, Showalter SL. Diabetes Mellitus and Metformin Are Not Associated With Breast Cancer Pathologic Complete Response. J Surg Res. 2019 Nov 28. PMID: 31787317.
      Citations:    
    57. Zheng R, Devin CL, Pucci MJ, Berger AC, Rosato EL, Palazzo F. Optimal timing and route of nutritional support after esophagectomy: A review of the literature. World J Gastroenterol. 2019 Aug 21; 25(31):4427-4436. PMID: 31496622.
      Citations:    
    58. Rios-Diaz AJ, Metcalfe D, Devin CL, Berger A, Palazzo F. Six-month readmissions after bariatric surgery: Results of a nationwide analysis. Surgery. 2019 Aug 06. PMID: 31399221.
      Citations:    
    59. Dupont E, Tsangaris T, Garcia-Cantu C, Howard-McNatt M, Chiba A, Berger AC, Levine EA, Gass JS, Gallagher K, Lum SS, Martinez RD, Willis AI, Pandya SV, Brown EA, Fenton A, Mendiola A, Murray M, Solomon NL, Senthil M, Ollila DW, Edmonson D, Lazar M, Namm JP, Li F, Butler M, McGowan NE, Herrera ME, Avitan YP, Yoder B, Walters LL, McPartland T, Chagpar AB. Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial. Ann Surg. 2019 Jul 08. PMID: 31290763.
      Citations:    
    60. Ecker BL, Vollmer CM, Behrman SW, Allegrini V, Aversa J, Ball CG, Barrows CE, Berger AC, Cagigas MN, Christein JD, Dixon E, Fisher WE, Freedman-Weiss M, Guzman-Pruneda F, Hollis RH, House MG, Kent TS, Kowalsky SJ, Malleo G, Salem RR, Salvia R, Schmidt CR, Seykora TF, Zheng R, Zureikat AH, Dickson PV. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma. JAMA Surg. 2019 May 29. PMID: 31141112.
      Citations:    
    61. Erkes DA, Field CO, Capparelli C, Tiago M, Purwin TJ, Chervoneva I, Berger AC, Hartsough EJ, Villanueva J, Aplin AE. The next generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner. Pigment Cell Melanoma Res. 2019 May 07. PMID: 31063649.
      Citations:    
    62. Chevrollier GS, Giugliano DN, Palazzo F, Keith SW, Rosato EL, Evans Iii NR, Berger AC. Patients with Non-response to Neoadjuvant Chemoradiation for Esophageal Cancer Have No Survival Advantage over Patients Undergoing Primary Esophagectomy. J Gastrointest Surg. 2019 Feb 26. PMID: 30809782.
      Citations:    
    63. Vetto JT, Hsueh EC, Gastman BR, Dillon LD, Monzon FA, Cook RW, Keller J, Huang X, Fleming A, Hewgley P, Gerami P, Leachman S, Wayne JD, Berger AC, Fleming MD. Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling. Future Oncol. 2019 Jan 29. PMID: 30691297.
      Citations:    
    64. Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H. Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA. Eur J Cancer. 2019 Jan; 106:133-143. PMID: 30528798.
      Citations:    
    65. Saleem MD, Oussedik E, Schoch JJ, Berger AC, Picardo M. Acquired disorders with depigmentation: A systematic approach to vitiliginoid conditions. J Am Acad Dermatol. 2018 Sep 17. PMID: 30236516.
      Citations:    
    66. Silvestri C, Christopher A, Intenzo C, Kairys JC, Kim S, Willis A, Berger AC. Consecutive Case Series of Melanoma Sentinel Node Biopsy for Lymphoseek Compared to Sulfur Colloids. J Surg Res. 2019 Jan; 233:149-153. PMID: 30502241.
      Citations:    
    67. Capparelli C, Purwin TJ, Heilman SA, Chervoneva I, McCue PA, Berger AC, Davies MA, Gershenwald JE, Krepler C, Aplin AE. ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma. Cancer Res. 2018 Oct 01; 78(19):5680-5693. PMID: 30115691.
      Citations:    
    68. Hassinger TE, Showalter TN, Schroen AT, Brenin DR, Berger AC, Libby B, Showalter SL. Utility of CT imaging in a novel form of high-dose-rate intraoperative breast radiation therapy. J Med Imaging Radiat Oncol. 2018 Aug 13. PMID: 30102019.
      Citations:    
    69. Moncrieff MD, Gyorki D, Saw R, Spillane AJ, Thompson JF, Peach H, Oudit D, Geh J, Dziewulsk P, Wilson E, Matteucci P, Pritchard-Jones R, Olofsson Bagge R, Wright FC, Crampton N, Cassell O, Jallali N, Berger A, Kelly J, Hamilton S, Durrani A, Lo S, Paton E, Henderson MA. Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study. Ann Surg Oncol. 2018 Jun 26. PMID: 29947003.
      Citations:    
    70. Moncrieff MD, Gyorki D, Saw R, Spillane AJ, Peach H, Oudit D, Geh J, Dziewulski P, Wilson E, Matteucci P, Pritchard-Jones R, Olofsson Bagge R, Wright FC, Crampton N, Cassell O, Jallali N, Berger A, Kelly J, Hamilton S, Durrani A, Lo S, Paton E, Henderson MA. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study. Ann Surg Oncol. 2018 May 30. PMID: 29850955.
      Citations:    
    71. Cho I, Al'Aref SJ, Berger A, Ă“ Hartaigh B, Gransar H, Valenti V, Lin FY, Achenbach S, Berman DS, Budoff MJ, Callister TQ, Al-Mallah MH, Cademartiri F, Chinnaiyan K, Chow BJW, DeLago A, Villines TC, Hadamitzky M, Hausleiter J, Leipsic J, Shaw LJ, Kaufmann PA, Feuchtner G, Kim YJ, Maffei E, Raff G, Pontone G, Andreini D, Marques H, Rubinshtein R, Chang HJ, Min JK. Prognostic value of coronary computed tomographic angiography findings in asymptomatic individuals: a 6-year follow-up from the prospective multicentre international CONFIRM study. Eur Heart J. 2018 03 14; 39(11):934-941. PMID: 29365193.
      Citations:    
    72. Hartsough EJ, Kugel CH, Vido MJ, Berger AC, Purwin TJ, Goldberg A, Davies MA, Schiewer MJ, Knudsen KE, Bollag G, Aplin AE. Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo. Mol Cancer Ther. 2018 Jan; 17(1):84-95. PMID: 29133617.
      Citations:    
    73. Monti D, Sotgia F, Whitaker-Menezes D, Tuluc M, Birbe R, Berger A, Lazar M, Cotzia P, Draganova-Tacheva R, Lin Z, Domingo-Vidal M, Newberg A, Lisanti MP, Martinez-Outschoorn U. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer. Semin Oncol. 2017 06; 44(3):226-232. PMID: 29248134.
      Citations:    
    74. Ecker BL, McMillan MT, Maggino L, Allegrini V, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dickson E, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Salem RR, Soares KC, Valero V, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM. Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies. J Gastrointest Surg. 2018 Jan; 22(1):68-76. PMID: 28840459.
      Citations:    
    75. Brown AM, Giugliano DN, Berger AC, Pucci MJ, Palazzo F. Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum. Langenbecks Arch Surg. 2017 Dec; 402(8):1153-1158. PMID: 28803334.
      Citations:    
    76. Giugliano DN, Berger AC, Pucci MJ, Rosato EL, Evans NR, Meidl H, Lamb C, Levine D, Palazzo F. Comparative Quantitative Lymph Node Assessment in Localized Esophageal Cancer Patients After R0 Resection With and Without Neoadjuvant Chemoradiation Therapy. J Gastrointest Surg. 2017 Jun 29. PMID: 28664255.
      Citations:    
    77. Brown AM, Pucci MJ, Berger AC, Tatarian T, Evans NR, Rosato EL, Palazzo F. A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown. Surg Endosc. 2017 Jun 22. PMID: 28643075.
      Citations:    
    78. Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med. 2017 06 08; 376(23):2211-2222. PMID: 28591523.
      Citations:    
    79. Ecker BL, McMillan MT, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Dickson EJ, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Javed AA, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Salem RR, Schmidt CR, Soares K, Stauffer JA, Valero V, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM. Characterization and Optimal Management of High-Risk Pancreatic Anastomoses During Pancreatoduodenectomy. Ann Surg. 2017 Jun 07. PMID: 28594741.
      Citations:    
    80. Tripathi SK, Kumar P, Trabulsi EJ, Kim S, McCue PA, Intenzo C, Berger A, Gomella L, Thakur ML. VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation. Nucl Med Biol. 2017 Aug; 51:55-61. PMID: 28577428.
      Citations:    
    81. Nam K, Eisenbrey JR, Stanczak M, Sridharan A, Berger AC, Avery T, Palazzo JP, Forsberg F. Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary Experience. Radiology. 2017 10; 285(1):53-62. PMID: 28467142.
      Citations:    
    82. Giugliano DN, Morgan A, Palazzo F, Leiby BE, Evans NR, Rosato EL, Berger AC. Surgical Apgar score (SAS) predicts perioperative morbidity, mortality, and length of stay in patients undergoing esophagectomy at a high-volume center. J Surg Oncol. 2017 Sep; 116(3):359-364. PMID: 28464255.
      Citations:    
    83. McMillan MT, Allegrini V, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dickson E, Dixon E, Drebin JA, Fernandez-Del Castillo C, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, McElhany AL, Salem RR, Soares KC, Sprys MH, Valero V, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM. Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy. Ann Surg. 2017 May; 265(5):978-986. PMID: 27232260.
      Citations:    
    84. Berger AC, Ollila DW, Christopher A, Kairys JC, Mastrangelo MJ, Feeney K, Dabbish N, Leiby B, Frank JA, Stitzenberg KB, Meyers MO. Patient Symptoms Are the Most Frequent Indicators of Recurrence in Patients with American Joint Committee on Cancer Stage II Melanoma. J Am Coll Surg. 2017 Apr; 224(4):652-659. PMID: 28189663.
      Citations:    
    85. Toss A, Palazzo J, Berger A, Guiles F, Sendecki JA, Simone N, Anne R, Avery T, Jaslow R, Lazar M, Tsangaris T, Cristofanilli M. Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less. Breast. 2016 Oct; 29:223-30. PMID: 27506636.
      Citations:    
    86. McMillan MT, Soi S, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, Miller BC, Salem RR, Soares K, Valero V, Wolfgang CL, Vollmer CM. Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation. Ann Surg. 2016 Aug; 264(2):344-52. PMID: 26727086.
      Citations:    
    87. Giugliano DN, Berger AC, Rosato EL, Palazzo F. Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes. Langenbecks Arch Surg. 2016 Sep; 401(6):747-56. PMID: 27401326.
      Citations:    
    88. Berger AC, Davidson RS, Poitras JK, Chabra I, Hope R, Brackeen A, Johnson CE, Maetzold DJ, Middlebrook B, Oelschlager KM, Cook RW, Monzon FA, Miller AR. Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients. Curr Med Res Opin. 2016 Sep; 32(9):1599-604. PMID: 27210115.
      Citations:    
    89. Boland PM, Meyer JE, Berger AC, Cohen SJ, Neuman T, Cooper HS, Olszanski AJ, Davey M, Cheng JD, Lebenthal A, Burtness BA, Scott WJ, Astsaturov IA. Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. Am J Clin Oncol. 2016 Mar 16. PMID: 26986978.
      Citations:    
    90. Tatarian T, Sokas C, Rufail M, Lazar M, Malhotra S, Palazzo JP, Hsu E, Tsangaris T, Berger AC. Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not? Ann Surg Oncol. 2016 Aug; 23(8):2501-7. PMID: 26960929.
      Citations:    
    91. Vu HL, Rosenbaum S, Capparelli C, Purwin TJ, Davies MA, Berger AC, Aplin AE. MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma. J Invest Dermatol. 2016 Feb; 136(2):453-63. PMID: 26967478.
      Citations:    
    92. Capparelli C, Rosenbaum S, Berger AC, Aplin AE. Fibroblast-derived Neuregulin 1 Promotes Compensatory ErbB3 Receptor Signaling in Mutant BRAF Melanoma. J Biol Chem. 2015 Oct 2; 290(40):24267-77. PMID: 26269601.
      Citations:    
    93. Murphy DT, Blanke P, Alaamri S, Naoum C, Rubinshtein R, Pache G, Precious B, Berger A, Raju R, Dvir D, Wood DA, Webb J, Leipsic JA. Dynamism of the aortic annulus: Effect of diastolic versus systolic CT annular measurements on device selection in transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 2016 Jan-Feb; 10(1):37-43. PMID: 26239964.
      Citations:    
    94. Dressler JA, Palazzo F, Berger AC, Stake S, Chaudhary A, Chojnacki KA, Rosato EL, Pucci MJ. Long-term functional outcomes of laparoscopic resection for gastric gastrointestinal stromal tumors. Surg Endosc. 2016 Apr; 30(4):1592-8. PMID: 26169640.
      Citations:    
    95. McMillan MT, Vollmer CM, Asbun HJ, Ball CG, Bassi C, Beane JD, Berger AC, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, McElhany AL, Salem RR, Soares K, Sprys MH, Valero V, Watkins AA, Wolfgang CL, Behrman SW. The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy. J Gastrointest Surg. 2016 Feb; 20(2):262-76. PMID: 26162925.
      Citations:    
    96. David SP, Johnson SG, Berger AC, Feero WG, Terry SF, Green LA, Phillips RL, Ginsburg GS. Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable. Ann Fam Med. 2015 Jul; 13(4):373-80. PMID: 26195686.
      Citations:    
    97. Manolio TA, Abramowicz M, Al-Mulla F, Anderson W, Balling R, Berger AC, Bleyl S, Chakravarti A, Chantratita W, Chisholm RL, W Dissanayake VH, Dunn M, Dzau VJ, Han BG, Hubbard T, Kolbe A, Korf B, Kubo M, Lasko P, Leego E, Mahasirimongkol S, Majumdar PP, Matthijs G, McLeod HL, Metspalu A, Meulien P, Miyano S, Naparstek Y, O'Rourke PP, Patrinos GP, Rehm HL, Relling MV, Rennert G, Rodriguez LL, Roden DM, Shuldiner AR, Sinha S, Tan P, Ulfendahl M, Ward R, Williams MS, L Wong JE, Green ED, Ginsburg GS. Global implementation of genomic medicine: We are not alone. Sci Transl Med. 2015 Jun 3; 7(290):290ps13. PMID: 26041702.
      Citations:    
    98. Hong TS, Moughan J, Garofalo MC, Bendell J, Berger AC, Oldenburg NB, Anne PR, Perera F, Lee RJ, Jabbour SK, Nowlan A, DeNittis A, Crane C. NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys. 2015 Sep 1; 93(1):29-36. PMID: 26163334.
      Citations:    
    99. Hansson NC, Nørgaard BL, Barbanti M, Nielsen NE, Yang TH, Tamburino C, Dvir D, Jilaihawi H, Blanke P, Makkar RR, Latib A, Colombo A, Tarantini G, Raju R, Wood D, Andersen HR, Ribeiro HB, Kapadia S, Min J, Feuchtner G, Gurvitch R, Alqoofi F, Pelletier M, Ussia GP, Napodano M, Sandoli de Brito F, Kodali S, Pache G, Canovas SJ, Berger A, Murphy D, Svensson LG, Rodés-Cabau J, Leon MB, Webb JG, Leipsic J. The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2015 Sep-Oct; 9(5):382-92. PMID: 26164109.
      Citations:    
    100. Berger AC. Melanoma. Surg Oncol Clin N Am. 2015 Apr; 24(2):xv-xvi. PMID: 25769720.
      Citations:    
    101. Yang TH, Webb JG, Blanke P, Dvir D, Hansson NC, Nørgaard BL, Thompson CR, Thomas M, Wendler O, Vahanian A, Himbert D, Kodali SK, Hahn RT, Thourani VH, Schymik G, Precious B, Berger A, Wood DA, Pibarot P, Rodés-Cabau J, Jaber WA, Leon MB, Walther T, Leipsic J. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. JACC Cardiovasc Interv. 2015 Mar; 8(3):462-71. PMID: 25790764.
      Citations:    
    102. Palazzo F, Rosato EL, Chaudhary A, Evans NR, Sendecki JA, Keith S, Chojnacki KA, Yeo CJ, Berger AC. Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction. J Am Coll Surg. 2015 Apr; 220(4):672-9. PMID: 25667145.
      Citations:    
    103. Blanke P, Dvir D, Cheung A, Ye J, Levine RA, Precious B, Berger A, Stub D, Hague C, Murphy D, Thompson C, Munt B, Moss R, Boone R, Wood D, Pache G, Webb J, Leipsic J. A simplified D-shaped model of the mitral annulus to facilitate CT-based sizing before transcatheter mitral valve implantation. J Cardiovasc Comput Tomogr. 2014 Nov-Dec; 8(6):459-67. PMID: 25467833.
      Citations:    
    104. Raju R, Thompson AG, Lee K, Precious B, Yang TH, Berger A, Taylor C, Heilbron B, Nguyen G, Earls J, Min J, Carrascosa P, Murphy D, Hague C, Leipsic JA. Reduced iodine load with CT coronary angiography using dual-energy imaging: A prospective randomized trial compared with standard coronary CT angiography. J Cardiovasc Comput Tomogr. 2014 Jul-Aug; 8(4):282-8. PMID: 25151920.
      Citations:    
    105. Liu JB, Merton DA, Berger AC, Forsberg F, Witkiewicz A, Zhao H, Eisenbrey JR, Fox TB, Goldberg BB. Contrast-enhanced sonography for detection of secondary lymph nodes in a melanoma tumor animal model. J Ultrasound Med. 2014 Jun; 33(6):939-47. PMID: 24866601.
      Citations:    
    106. Power A, Berger AC, Ginsburg GS. Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity. JAMA. 2014 May 28; 311(20):2063-4. PMID: 24867009.
      Citations:    
    107. Shi W, Lawrence YR, Choy H, Werner-Wasik M, Andrews DW, Evans JJ, Judy KD, Farrell CJ, Moshel Y, Berger AC, Bar-Ad V, Dicker AP. Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial. J Neurooncol. 2014 Jun; 118(2):313-9. PMID: 24728831.
      Citations:    
    108. Keller DS, Thomay AA, Gaughan J, Olszanski A, Wu H, Berger AC, Farma JM. Outcomes in patients with mucosal melanomas. J Surg Oncol. 2013 Dec; 108(8):516-20. PMID: 24132665.
      Citations:    
    109. Bosch B, Berger AC, Khandelwal S, Heipertz EL, Scharf B, Santambrogio L, Roche PA. Disruption of Multivesicular Body Vesicles Does Not Affect Major Histocompatibility Complex (MHC) Class II-Peptide Complex Formation and Antigen Presentation by Dendritic Cells. J Biol Chem. 2013 Aug 23; 288(34):24286-92. PMID: 23846690.
      Citations:    
    110. Chen KT, Papavasiliou P, Edwards K, Zhu F, Perlis C, Wu H, Turaka A, Berger A, Farma JM. A better prognosis for Merkel cell carcinoma of unknown primary origin. Am J Surg. 2013 Nov; 206(5):752-7. PMID: 23835211.
      Citations:    
    111. Simone BA, Champ CE, Rosenberg AL, Berger AC, Monti DA, Dicker AP, Simone NL. Selectively starving cancer cells through dietary manipulation: methods and clinical implications. Future Oncol. 2013 Jul; 9(7):959-76. PMID: 23837760.
      Citations:    
    112. Assifi MM, Zhang S, Leiby BE, Pequignot EC, Xia B, Rosato E, Lavu H, Kennedy EP, Yeo CJ, Berger AC. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Am Coll Surg. 2013 Oct; 217(4):621-7. PMID: 23810574.
      Citations:    
    113. Thakur ML, Zhang K, Berger A, Cavanaugh B, Kim S, Channappa C, Frangos AJ, Wickstrom E, Intenzo CM. VPAC1 Receptors for Imaging Breast Cancer: A Feasibility Study. J Nucl Med. 2013 Jul; 54(7):1019-25. PMID: 23651947.
      Citations:    
    114. Johnson C, Intenzo C, Mastrangelo MJ, Feeney K, Berger AC. Altered drainage patterns in patients with melanoma and previous axillary dissection. J Dermatol. 2013 Jul; 40(7):564-6. PMID: 23594177.
      Citations:    
    115. Peters MG, Berger AC, Schwartz GF, Yeo CJ, Cowan SW. John Chalmers DaCosta (1863-1933): Restoration of the Old Operating Table. Am Surg. 2013 Mar; 79(3):232-4. PMID: 23461945.
      Citations:    
    116. Xia BT, Rosato EL, Chojnacki KA, Crawford AG, Weksler B, Berger AC. Major perioperative morbidity does not affect long-term survival in patients undergoing esophagectomy for cancer of the esophagus or gastroesophageal junction. World J Surg. 2013 Feb; 37(2):408-15. PMID: 23052816.
      Citations:    
    117. Weiss MB, Abel EV, Mayberry MM, Basile KJ, Berger AC, Aplin AE. TWIST1 Is an ERK1/2 Effector That Promotes Invasion and Regulates MMP-1 Expression in Human Melanoma Cells. Cancer Res. 2012 Dec 15; 72(24):6382-92. PMID: 23222305.
      Citations:    
    118. Relles DM, Richards NG, Bloom JP, Kennedy EP, Sauter PK, Leiby BE, Rosato EL, Yeo CJ, Berger AC. Serum blood urea nitrogen and serum albumin on the first postoperative day predict pancreatic fistula and major complications after pancreaticoduodenectomy. J Gastrointest Surg. 2013 Feb; 17(2):326-31. PMID: 23225108.
      Citations:    
    119. Auriemma WS, Berger AC, Bar-Ad V, Boland PM, Cohen SJ, Roche-Lima CM, Morris GJ. Locally advanced pancreatic cancer. Semin Oncol. 2012 Aug; 39(4):e9-22. PMID: 22846869.
      Citations:    
    120. Fong ZV, Wolf AM, Doria C, Berger AC, Rosato EL, Palazzo F. Hemorrhagic hepatic cyst: report of a case and review of the literature with emphasis on clinical approach and management. J Gastrointest Surg. 2012 Sep; 16(9):1782-9. PMID: 22688416.
      Citations:    
    121. Berger AC, Winter K, Hoffman JP, Regine WF, Abrams RA, Safran H, Freedman GM, Benson AB, Macdonald J, Willett CG. Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 =90 U/mL and comparison to the CONKO-001 trial. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):e291-7. PMID: 22682806.
      Citations:    
    122. Pucci MJ, Berger AC, Lim PW, Chojnacki KA, Rosato EL, Palazzo F. Laparoscopic approaches to gastric gastrointestinal stromal tumors: an institutional review of 57 cases. Surg Endosc. 2012 Dec; 26(12):3509-14. PMID: 22684977.
      Citations:    
    123. Arrangoiz R, Papavasiliou P, Stransky CA, Yu JQ, Tianyu L, Sigurdson ER, Berger AC, Farma JM. Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma. Dermatol Res Pract. 2012; 2012:614349. PMID: 22654898.
      Citations:    
    124. Assifi MM, Lindenmeyer J, Leiby BE, Grunwald Z, Rosato EL, Kennedy EP, Yeo CJ, Berger AC. Surgical Apgar score predicts perioperative morbidity in patients undergoing pancreaticoduodenectomy at a high-volume center. J Gastrointest Surg. 2012 Feb; 16(2):275-81. PMID: 22033701.
      Citations:    
    125. Miller-Samuel S, Rosenberg A, Berger A, Gomella L, Loren D, Morris GJ. BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management. Semin Oncol. 2011 Oct; 38(5):605-11. PMID: 21943665.
      Citations:    
    126. Berger AC, Fierro M, Kairys JC, Berd D, Sato T, Andrel J, Hyslop T, Mastrangelo MJ. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma. J Surg Oncol. 2012 Jan; 105(1):15-20. PMID: 21815149.
      Citations:    
    127. Showalter TN, Zhan T, Anne PR, Chervoneva I, Mitchell EP, Yeo CJ, Rosato EL, Kennedy EP, Berger AC. The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma. J Gastrointest Surg. 2011 Aug; 15(8):1411-6. PMID: 21523621.
      Citations:    
    128. Hager ES, Abdollahi H, Crawford AG, Moudgill N, Rosato EL, Chojnacki KA, Yeo CJ, Kennedy EP, Berger A. Is gastrectomy safe in the elderly? A single institution review. Am Surg. 2011 Apr; 77(4):488-92. PMID: 21679562.
      Citations:    
    129. Berger AC, Bloomenthal A, Weksler B, Evans N, Chojnacki KA, Yeo CJ, Rosato EL. Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy. J Am Coll Surg. 2011 Apr; 212(4):560-6; discussion 566-8. PMID: 21463789.
      Citations:    
    130. Fogh SE, Yu A, Kubicek GJ, Scott W, Mitchell E, Rosato EL, Berger AC. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy? Int J Radiat Oncol Biol Phys. 2011 Aug 1; 80(5):1372-6. PMID: 21106309.
      Citations:    
    131. Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys. 2011 Dec 1; 81(5):1328-35. PMID: 20934270.
      Citations:    
    132. Wu KN, McCue PA, Berger A, Spiegel JR, Wang ZX, Witkiewicz AK. Detection of Merkel cell carcinoma polyomavirus in mucosal Merkel cell carcinoma. Int J Surg Pathol. 2010 Oct; 18(5):342-6. PMID: 20484140.
      Citations:    
    133. Harris LJ, Abdollahi H, Newhook T, Sauter PK, Crawford AG, Chojnacki KA, Rosato EL, Kennedy EP, Yeo CJ, Berger AC. Optimal technical management of stump closure following distal pancreatectomy: a retrospective review of 215 cases. J Gastrointest Surg. 2010 Jun; 14(6):998-1005. PMID: 20306151.
      Citations:    
    134. Marks JA, Rao AS, Loren D, Witkiewicz A, Mastrangelo MJ, Berger AC. Malignant melanoma presenting as obstructive jaundice secondary to metastasis to the Ampulla of Vater. JOP. 2010; 11(2):173-5. PMID: 20208330.
      Citations:    
    135. Showalter SL, Rosato EL, Anne PR, Scott W, Mitchell E, Berger AC. Does diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal cancer? A two-institution report. J Surg Oncol. 2010 Jan 1; 101(1):43-6. PMID: 19798684.
      Citations:    
    136. Berger AC, McClay EF, Toporcer M, Wolchok JD, Morris GJ. Completely regressed cutaneous melanocytic lesion: was it benign or was it malignant? Semin Oncol. 2009 Oct; 36(5):375-9. PMID: 19835734.
      Citations:    
    137. Lavu H, Mascaro AA, Grenda DR, Sauter PK, Leiby BE, Croker SP, Witkiewicz A, Berger AC, Rosato EL, Kennedy EP, Yeo CJ. Margin positive pancreaticoduodenectomy is superior to palliative bypass in locally advanced pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2009 Nov; 13(11):1937-46; discussion 1946-7. PMID: 19760308.
      Citations:    
    138. Intenzo CM, Truluck CA, Kushen MC, Kim SM, Berger A, Kairys JC. Lymphoscintigraphy in cutaneous melanoma: an updated total body atlas of sentinel node mapping. Radiographics. 2009 Jul-Aug; 29(4):1125-35. PMID: 19605661.
      Citations:    
    139. Brody JR, Costantino CL, Berger AC, Sato T, Lisanti MP, Yeo CJ, Emmons RV, Witkiewicz AK. Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival. Cell Cycle. 2009 Jun 15; 8(12):1930-4. PMID: 19448397.
      Citations:    
    140. Showalter TN, Rao AS, Rani Anne P, Rosato FE, Rosato EL, Andrel J, Hyslop T, Xu X, Berger AC. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis. Ann Surg Oncol. 2009 Aug; 16(8):2116-22. PMID: 19437078.
      Citations:    
    141. Berger AC, Howard TJ, Kennedy EP, Sauter PK, Bower-Cherry M, Dutkevitch S, Hyslop T, Schmidt CM, Rosato EL, Lavu H, Nakeeb A, Pitt HA, Lillemoe KD, Yeo CJ. Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg. 2009 May; 208(5):738-47; discussion 747-9. PMID: 19476827.
      Citations:    
    142. Morris GJ, Berger AC, Emanuelson RG, Jordan WE, McGuire K, Thomas LC. Breast cancer with positive sentinel lymph node: now what? Semin Oncol. 2009 Apr; 36(2):84-9. PMID: 19332242.
      Citations:    
    143. Kennedy EP, Grenda TR, Sauter PK, Rosato EL, Chojnacki KA, Rosato FE, Profeta BC, Doria C, Berger AC, Yeo CJ. Implementation of a critical pathway for distal pancreatectomy at an academic institution. J Gastrointest Surg. 2009 May; 13(5):938-44. PMID: 19190968.
      Citations:    
    144. Berger AC, Roche PA. MHC class II transport at a glance. J Cell Sci. 2009 Jan 1; 122(Pt 1):1-4. PMID: 19092054.
      Citations:    
    145. Williams TK, Rosato EL, Kennedy EP, Chojnacki KA, Andrel J, Hyslop T, Doria C, Sauter PK, Bloom J, Yeo CJ, Berger AC. Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg. 2009 Feb; 208(2):210-7. PMID: 19228532.
      Citations:    
    146. Berger AC, Garcia M, Hoffman JP, Regine WF, Abrams RA, Safran H, Konski A, Benson AB, MacDonald J, Willett CG. Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol. 2008 Dec 20; 26(36):5918-22. PMID: 19029412.
      Citations:    
    147. Berger AC. Introduction: role of surgery in the diagnosis and management of metastatic cancer. Semin Oncol. 2008 Apr; 35(2):98-9. PMID: 18396194.
      Citations:    
    148. Qiu H, Eifert J, Wacheul L, Thiry M, Berger AC, Jakovljevic J, Woolford JL, Corbett AH, Lafontaine DL, Terns RM, Terns MP. Identification of genes that function in the biogenesis and localization of small nucleolar RNAs in Saccharomyces cerevisiae. Mol Cell Biol. 2008 Jun; 28(11):3686-99. PMID: 18378690.
      Citations:    
    149. Showalter SL, Lloyd JM, Glassman DT, Berger AC. Extra-gastrointestinal stromal tumor of the pancreas: case report and a review of the literature. Arch Surg. 2008 Mar; 143(3):305-8. PMID: 18347279.
      Citations:    
    150. Samplaski MK, Rosato EL, Witkiewicz AK, Mastrangelo MJ, Berger AC. Malignant melanoma of the gallbladder: a report of two cases and review of the literature. J Gastrointest Surg. 2008 Jun; 12(6):1123-6. PMID: 18060465.
      Citations:    
    151. Berger AC, Salazar G, Styers ML, Newell-Litwa KA, Werner E, Maue RA, Corbett AH, Faundez V. The subcellular localization of the Niemann-Pick Type C proteins depends on the adaptor complex AP-3. J Cell Sci. 2007 Oct 15; 120(Pt 20):3640-52. PMID: 17895371.
      Citations:    
    152. Muntasell A, Berger AC, Roche PA. T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes. EMBO J. 2007 Oct 3; 26(19):4263-72. PMID: 17805347.
      Citations:    
    153. Wilson M, Rosato EL, Chojnacki KA, Chervoneva I, Kairys JC, Cohn HE, Rosato FE, Berger AC. Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res. 2008 May 1; 146(1):11-5. PMID: 18028955.
      Citations:    
    154. Mucci T, Long W, Witkiewicz A, Mastrangelo MJ, Rosato EL, Berger AC. Metastatic melanoma causing jejunal intussusception. J Gastrointest Surg. 2007 Dec; 11(12):1755-7. PMID: 17619936.
      Citations:    
    155. Kennedy EP, Rosato EL, Sauter PK, Rosenberg LM, Doria C, Marino IR, Chojnacki KA, Berger AC, Yeo CJ. Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution--the first step in multidisciplinary team building. J Am Coll Surg. 2007 May; 204(5):917-23; discussion 923-4. PMID: 17481510.
      Citations:    
    156. Schiffman S, Berger A. Stewart-Treves syndrome. J Am Coll Surg. 2007 Feb; 204(2):328. PMID: 17254938.
      Citations:    
    157. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005 Dec 1; 23(34):8706-12. PMID: 16314630.
      Citations:    
    158. Berger AC, Scott WJ, Freedman G, Konski A, Weiner L, Cheng JD, Goldberg M. Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer. Semin Oncol. 2005 Dec; 32(6 Suppl 9):S16-20. PMID: 16399424.
      Citations:    
    159. Berger AC, Vanderford TH, Gernert KM, Nichols JW, Faundez V, Corbett AH. Saccharomyces cerevisiae Npc2p is a functionally conserved homologue of the human Niemann-Pick disease type C 2 protein, hNPC2. Eukaryot Cell. 2005 Nov; 4(11):1851-62. PMID: 16278452.
      Citations:    
    160. Berger AC, Hanson PK, Wylie Nichols J, Corbett AH. A yeast model system for functional analysis of the Niemann-Pick type C protein 1 homolog, Ncr1p. Traffic. 2005 Oct; 6(10):907-17. PMID: 16138904.
      Citations:    
    161. Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD, Wang H, Goldberg M. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol. 2005 Jul 1; 23(19):4330-7. PMID: 15781882.
      Citations:    
    162. Berger AC, Wang XQ, Zalatoris A, Cenna J, Watson JC. A murine model of ex vivo angiogenesis using aortic disks grown in fibrin clot. Microvasc Res. 2004 Nov; 68(3):179-87. PMID: 15501237.
      Citations:    
    163. Berger A, Henry L, Goldberg M. Surgical palliation of thoracic malignancies. Surg Oncol Clin N Am. 2004 Jul; 13(3):429-53, viii. PMID: 15236727.
      Citations:    
    164. Berger AC, Meszoely IM, Ross EA, Watson JC, Hoffman JP. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2004 Jul; 11(7):644-9. PMID: 15197014.
      Citations:    
    165. Berger AC, Scott WJ. Noninvasive staging of esophageal carcinoma. J Surg Res. 2004 Mar; 117(1):127-33. PMID: 15013723.
      Citations:    
    166. Berger AC, Watson JC, Ross EA, Hoffman JP. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg. 2004 Mar; 70(3):235-40; discussion 240. PMID: 15055847.
      Citations:    
    167. Berger AC, Watson JC, Ross EA, Zalatoris A, Hoffman JP. Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma. Am Surg. 2004 Feb; 70(2):169-73; discussion 173-4. PMID: 15011922.
      Citations:    
    Berger's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (335)
    Explore
    _
    Co-Authors (100)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _